Protease inhibitor exposure and increased risk of cardiovascular disease in HIV‐infected patients

Abstract

Patients exposed to PI therapy had an increased risk of CVD events. Clinicians should evaluate the risk of CVD when making treatment decisions for HIV-infected patients.